GSDMD and cancer: A prognostic model based on four cancer stem cell-related gene signatures has been developed for pancreatic ductal adenocarcinoma, revealing that high expression of the GSDMD gene is associated with unfavorable outcomes (AUCs: 1 year: 0.722; 2 years: 0.862) [99].